Pulse Biosciences enrolled 164 patients in its pivotal NANOPULSE-AF study ahead of schedule, demonstrating strong investigator interest in its cardiac catheter system.
Pulse Biosciences enrolled 164 patients in its pivotal NANOPULSE-AF study ahead of schedule, demonstrating strong investigator interest in its cardiac catheter system.